GK PHARMA ApS: Financial statements 2014
CVR: 81267316
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
GK PHARMA ApS (CVR 81267316) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 9,257,185 and a net result of DKK -789,605 compared with DKK 55,680 the year before. That is an increase of 19.7% compared with the year before. The profit margin was -8.5%. Equity in the 2014 report amounted to DKK -475,829.
- Revenue
- DKK 9,257,185
- Gross Profit
- DKK 2,185,702
- Profit/Loss
- DKK -789,605
- Equity
- DKK -475,829
- Total Assets
- DKK 3,302,251
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 9.3 mio. | 2.2 mio. | -790 t. | -476 t. | - |
| 2013 | 7.7 mio. | 2.5 mio. | 56 t. | 314 t. | - |
| 2012 | 7.7 mio. | 2.4 mio. | 30 t. | 258 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
GK PHARMA ApS has published its annual report for 2013. Revenue came to DKK 7,731,774, and the net result was DKK 55,680.
As of May 19, 2014, Lars Skov Ibsen has joined the board of directors of GK PHARMA ApS.
As of May 19, 2014, Lars Skov Ibsen is registered as adm. dir. of GK PHARMA ApS.
As of January 31, 2014, Andrew John Reks Jacobsen has left the board of directors of GK PHARMA ApS.
As of January 31, 2014, Andrew John Reks Jacobsen has stepped down as director of GK PHARMA ApS.
About GK PHARMA ApS
GK PHARMA ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 1977. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Klaus Groth. The board consists of Dorthe Groth (chair) and Klaus Groth. The company is owned by Salvefabrikken ApS. The company has 10 employees (2018). In 2025, the company reported a gross profit of DKK 5,931,212 and a net result of DKK 2,646,889 compared with DKK 954,244 the year before. Equity in the 2025 report amounted to DKK 4,029,041.